NYSE · TMO
Thermo Fisher Scientific Inc
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for TMO has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Dec 2026 | $7.15 | $7.36 | $7.09 | 8 |
| Mar 2027 | $5.98 | $6.13 | $5.64 | 5 |
| Jun 2027 | $6.55 | $6.62 | $6.41 | 5 |
| Sep 2027 | $7.12 | $7.25 | $6.86 | 5 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · Fintel · The Motley Fool · BNK Invest- Zacks · Oct 30, 6:28 AM EDTRMD Stock Up on Q1 Earnings and Revenue Beat, Gross Margin ClimbsResMed's first-quarter fiscal 2027 earnings and revenues top estimates as sustained sleep device demand, productivity gains and gross margin expansion drive growth.
- Zacks · Oct 27, 3:09 PM EDTTop Research Reports for Alphabet, ExxonMobil & Toyota MotorAlphabet, ExxonMobil and Toyota Motor headline today's top research reports, highlighting AI growth, energy cash generation and hybrid vehicle opportunities.
- Fintel · Oct 21, 4:49 PM EDTThermo Fisher Scientific Inc. Reports Third Quarter 2026 ResultsThermo Fisher Scientific Inc. reported its financial results for the third quarter ended September 26, 2026. Revenue for the quarter grew 9% to $12.14 billion, compared with $11.12 billion in the third quarter of 2025, with organic revenue growth of 6%. GAAP diluted earnings per
- The Motley Fool · Oct 21, 3:02 PM EDTThermo Fisher Scientific: 3 Key Takeaways for Long-Term InvestorsThermo Fisher raised its 2026 organic revenue growth outlook to 4%.
- The Motley Fool · Oct 21, 1:17 PM EDTThermo Fisher (TMO) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- BNK Invest · Oct 21, 10:59 AM EDTState Street Health Care Select Sector SPDR ETF Experiences Big InflowLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the State Street Health Care Select Sector SPDR ETF (Symbol: XLV) where we have detected an approximate $530.5 million dollar inflow — that's a 1.1% inc
- MarketBeat · Oct 21, 10:02 AM EDTThermo Fisher Scientific Q3 Earnings Call HighlightsQuantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets BuiltThermo Fisher Scientific (NYSE:TMO) reported third-quarter revenue growth of 9% to $12.14 billion, supported by 6% organic growth, acquisitions and foreign-exchange effects. Adjusted earnings per share rose
- Zacks · Oct 21, 8:31 AM EDTTMO Q3 Earnings & Revenues Beat Estimates, Stock Down in Pre-MarketThermo Fisher beats Q3 earnings and revenue estimates, with double-digit profit growth and wider margins, yet shares fall 4.1% in pre-market trading.
- Zacks · Oct 21, 8:30 AM EDTCompared to Estimates, Thermo Fisher (TMO) Q3 Earnings: A Look at Key MetricsAlthough the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- RTTNews · Oct 21, 7:08 AM EDTThermo Fisher Q3 Net Income Rises 6.2% As Revenue Climbs 9%(RTTNews) – Thermo Fisher Scientific Inc. (TMO) reported Wednesday that third-quarter revenue rose 9% to $12.14 billion from $11.12 billion a year earlier, while net income attributable to the company increased approximately by 6.2%.
- Zacks · Oct 21, 6:10 AM EDTThermo Fisher Scientific (TMO) Tops Q3 Earnings and Revenue EstimatesThermo Fisher (TMO) delivered earnings and revenue surprises of +4.38% and +1.81%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Oct 21, 6:05 AM EDTThermo Fisher Scientific Profit Climbs In Q3(RTTNews) – Thermo Fisher Scientific (TMO) revealed earnings for its third quarter that Increases, from the same period last year
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Thermo Fisher Scientific Inc from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.